CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Choice of Assignment: Opt-inWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (7)


Name (Synonyms) Correlation
drug273 Assigned Strategies: Enhanced Active Choice Wiki 1.00
drug272 Assigned Strategies: Active Choice Wiki 1.00
drug665 Choice of Assignment: Enhanced Active Choice Wiki 1.00
drug84 AMY-101 Wiki 1.00
drug664 Choice of Assignment: Active Choice Wiki 1.00
drug3099 WFI 5% glucose Wiki 1.00
drug274 Assigned Strategies: Opt-in Wiki 1.00

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.10
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.09
D012128 Respiratory Distress Syndrome, Adult NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers, a Pilot Randomized Controlled Trial

In COVID-19 times, there has been a large increase in number of people working from home; with limited places to go, an abrupt change to people's lives and lack of knowledge about the dangers of sedentary behaviour (SB), it is important to help workers develop and effortlessly incorporate healthy movement routines to optimize daily productivity and health. The combined lack of knowledge on literature on SB profiles of full time, home-based workers, effects of framing of SB reduction strategies, and strategy preference uncertainty makes for a novel study. This will be a 4-week intervention that looks at whether telling a full time, home-based office worker to do pre-selected strategies using different framing structures to break up their sedentary behaviour (SB) (i.e. sitting) will change their SB profiles. Investigators are looking to see whether having the choice (or not) to choose strategies in an unfamiliar health related selection (preference uncertainty) will create greater changes in SBs. As well, the researchers are incorporating behavioural economics' by altering choice structure in relation to behaviour change and program engagement. Workers' work-related SB will be measured by a device at baseline and on the last week of the intervention. Workers will be provided with an SB educational video to increase knowledge and motivation for change. Any SB changes in relation to productivity, mental wellness, behaviour intentions etc. will also be measured.

NCT04488796 Health Behaviour Change Behavioral: Assigned Strategies: Opt-in Behavioral: Assigned Strategies: Active Choice Behavioral: Assigned Strategies: Enhanced Active Choice Behavioral: Choice of Assignment: Opt-in Behavioral: Choice of Assignment: Active Choice Behavioral: Choice of Assignment: Enhanced Active Choice

Primary Outcomes

Description: measured via ActivPAL

Measure: Change in sedentary behaviour break frequency

Time: change from baseline to 4 weeks

Description: measured via ActivPAL

Measure: Change in sedentary behaviour break duration

Time: change from baseline to 4 weeks

Secondary Outcomes

Description: Short form 36 health survey (SF-36) measured on a 5-point Likert scale from 1 "all of the time" to 5 "None of the time".

Measure: Change in work-related quality of life

Time: change from baseline to 6 weeks

Description: Questions regarding work productivity, concentration and focus will be measured with questions adapted from The Health and Work Questionnaire (HWQ). The HWQ is a multidimensional tool used to measure various aspects of productivity. The HWQ consists of 24 questions, several items being multi-part questions with internal consistency scores ranging from alpha = 0.72 to 0.96. The questions are designed to assess work quality, quantity, and efficiency, as well as impatience, concentration/focus, work satisfaction and non-work satisfaction. For the current study, 15 items were chosen from this questionnaire that were relevant to "home-based" office workers. Items will be assessed with a ten-point response scale, tailored to each question (e.g., "my worst ever" to "my best ever").

Measure: Change in Health outcomes

Time: change from baseline to 6 weeks

Description: measured with the ActivPAL4

Measure: Change in sitting time

Time: change in baseline to 4 weeks

Description: measured with the ActivPAL4

Measure: Change in standing time

Time: change in baseline to 4 weeks

Description: measured with the ActivPAL4

Measure: Change in moving time

Time: change in baseline to 4 weeks

Description: measured with the ActivPAL4

Measure: Change in prolonged sitting bouts

Time: change in baseline to 4 weeks

Description: The validated three-item modified Occupational Sitting and Physical activity questionnaire (OSPAQ). The OSPAQ is a brief instrument reported to have excellent test-retest reliability (intraclass correlation coefficients = 0.73-0.90), moderate criterion validity for time spent sitting and standing (r = 0.65 and 0.49, respectively), and lower validity for time spent walking (r = 0.29). At each assessment period (baseline, week 1, week 2, week 3, week 4 and follow-up), participants will be asked to record both the number of days they were at work and total number of hours they worked in the last 7 days. Participants will then be asked to record a percentage of time spent sitting, standing, and moving (i.e. walking) (cumulative total of 100%) during work hours on a typical workday in the last 7 days.

Measure: Change in percentage of time spent sitting

Time: change from baseline to 6 weeks

Description: The validated three-item modified Occupational Sitting and Physical activity questionnaire (OSPAQ). The OSPAQ is a brief instrument reported to have excellent test-retest reliability (intraclass correlation coefficients = 0.73-0.90), moderate criterion validity for time spent sitting and standing (r = 0.65 and 0.49, respectively), and lower validity for time spent walking (r = 0.29). At each assessment period (baseline, week 1, week 2, week 3, week 4 and follow-up), participants will be asked to record both the number of days they were at work and total number of hours they worked in the last 7 days. Participants will then be asked to record a percentage of time spent sitting, standing, and moving (i.e. walking) (cumulative total of 100%) during work hours on a typical workday in the last 7 days.

Measure: Change in percentage of time spent standing

Time: change from baseline to 6 weeks

Description: The validated three-item modified Occupational Sitting and Physical activity questionnaire (OSPAQ). The OSPAQ is a brief instrument reported to have excellent test-retest reliability (intraclass correlation coefficients = 0.73-0.90), moderate criterion validity for time spent sitting and standing (r = 0.65 and 0.49, respectively), and lower validity for time spent walking (r = 0.29). At each assessment period (baseline, week 1, week 2, week 3, week 4 and follow-up), participants will be asked to record both the number of days they were at work and total number of hours they worked in the last 7 days. Participants will then be asked to record a percentage of time spent sitting, standing, and moving (i.e. walking) (cumulative total of 100%) during work hours on a typical workday in the last 7 days.

Measure: Change in percentage of time spent moving

Time: change from baseline to 6 weeks

Description: measured using a modified version of the SIT-Q 7d;modified the base questionnaire to include domain-specific (work-related) break frequency and duration scores, which were the only items assessed for purposes of this study

Measure: Change in sedentary break frequency

Time: change from baseline to 6 weeks

Description: measured using a modified version of the SIT-Q 7d;modified the base questionnaire to include domain-specific (work-related) break frequency and duration scores, which were the only items assessed for purposes of this study

Measure: Change in sedentary break duration

Time: change from baseline to 6 weeks


No related HPO nodes (Using clinical trials)